drugset / Trial / NCT01058447

Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers

NCT01058447

Phase 1 Completed 4 enrolled AstraZeneca
NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to characterize the absorption, distribution, metabolism and excretion (ADME) of a single oral dose of \[14C\]AZD1981

Timeline

Start
2010-02
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1981 Small molecule 250 mg Oral

Indications

No indication recorded.